AKCA - Akcea Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Akcea Therapeutics's activity chart (see below) currently has 28 price targets and 24 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 21.4 days.

Most recent stock forecast was given by from on 01-Sep-2020. First documented stock forecast 08-Aug-2017.

Best performing analysts who are covering AKCA - Akcea Therapeutics:

Do Kim Jim Birchenough Stephen Willey Paul Matteis Chad Messer

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 25-Sep-2018

$20

$1.83 (10.07%)

$31

Buy Since 07-Oct-2019

$45

$26.83 (147.66%)

$45

Show more analysts

Please expand the browser size to see the chart

What is AKCA (Akcea Therapeutics) average time for price targets to be met?

On average it took 21.4 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on AKCA (Akcea Therapeutics) with a proven track record?

DO KIM

Which analyst has the most public recommendations on AKCA (Akcea Therapeutics)?

Do Kim has 7 price targets and 8 ratings on AKCA

Which analyst is the currently most bullish on AKCA (Akcea Therapeutics)?

Chad Messer with highest potential upside - $26.83

Which analyst is the currently most reserved on AKCA (Akcea Therapeutics)?

Do Kim with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?